Create a billable SOAP note for a patient presenting with vaginal itching, thin white discharge, and malodorous urine, including assessment and plan for presumptive vulvovaginal candidiasis and possible urinary tract infection.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

SOAP Note for Vaginal Itching and Urine Odor

SUBJECTIVE

Chief Complaint: Vaginal itching and urine odor

History of Present Illness:

  • Duration and onset of vaginal itching (acute vs. chronic)
  • Character of vaginal discharge (color, consistency, amount): specifically assess for white, thick, curd-like discharge suggesting candidiasis vs. thin, homogenous discharge with fishy odor suggesting bacterial vaginosis
  • Presence of vulvar burning, dyspareunia, or external dysuria
  • Urinary symptoms: dysuria, frequency, urgency, hematuria, new incontinence
  • Recent antibiotic use (precipitates VVC in minority of colonized women) 1
  • Sexual activity and partner symptoms
  • Previous episodes of similar symptoms
  • Self-treatment attempts with OTC preparations
  • Pregnancy status
  • Immunocompromising conditions (diabetes, HIV, immunosuppression)

Review of Systems:

  • Constitutional: fever, chills (suggests upper tract involvement)
  • GU: vaginal irritation, increased vaginal discharge, lower back pain
  • Absence of concomitant vaginal irritation increases specificity of dysuria for UTI 2

OBJECTIVE

Vital Signs: Temperature, blood pressure, pulse

Physical Examination:

  • Abdominal exam: Suprapubic tenderness, costovertebral angle tenderness (rule out pyelonephritis)
  • Pelvic examination: 2
    • External genitalia: vulvar erythema, excoriation from scratching
    • Speculum exam: vaginal erythema, character of discharge (white/thick vs. thin/homogenous), cervical erythema with petechiae (trichomoniasis)
    • Bimanual exam: cervical motion tenderness, adnexal tenderness
    • Pelvic support assessment for structural abnormalities

Laboratory Studies:

  • Vaginal wet mount preparation:
    • Saline microscopy: assess for motile trichomonads, clue cells
    • 10% KOH preparation: improves visualization of yeast pseudohyphae or budding yeast 1
    • Whiff test: fishy odor with KOH (bacterial vaginosis)
  • Vaginal pH: Normal pH <4.5 supports candidiasis; elevated pH suggests bacterial vaginosis or trichomoniasis 1
  • Urinalysis with microscopy: Pyuria (>5 WBC/hpf) supports UTI diagnosis 2
  • Urine culture: If UTI suspected based on symptoms + pyuria
  • Consider vaginal culture: If recurrent symptoms, treatment failure, or non-albicans species suspected 1

ASSESSMENT

Primary Diagnoses:

  1. Vulvovaginal Candidiasis (Uncomplicated) - if pruritus, erythema, white discharge, normal pH, and yeast/pseudohyphae visualized 1

  2. Urinary Tract Infection (Acute Uncomplicated Cystitis) - if acute dysuria, frequency, urgency with pyuria on urinalysis 2

Differential Diagnoses:

  • Bacterial vaginosis (thin discharge, fishy odor, elevated pH, clue cells)
  • Trichomoniasis (frothy discharge, cervical petechiae, motile organisms)
  • Mixed vaginitis (VVC can occur concomitantly with other infections) 1
  • Atrophic vaginitis (if postmenopausal)

PLAN

For Vulvovaginal Candidiasis:

First-Line Treatment (choose one regimen) 1:

Intravaginal azoles (80-90% cure rate):

  • Clotrimazole 1% cream 5g intravaginally for 7 days, OR
  • Clotrimazole 100mg vaginal tablet for 7 days, OR
  • Miconazole 2% cream 5g intravaginally for 7 days, OR
  • Terconazole 0.4% cream 5g intravaginally for 7 days

Oral azole:

  • Fluconazole 150mg PO single dose (if not pregnant) 3

Key Points:

  • Topical azoles are more effective than nystatin 1
  • Short-course regimens (1-3 days) are effective for uncomplicated VVC 1
  • OTC preparations (miconazole, clotrimazole) available for self-treatment in women with previously diagnosed VVC 3
  • Avoid fluconazole in pregnancy; use topical azoles for 7 days 4, 5

For Urinary Tract Infection:

Antibiotic Selection (based on local resistance patterns and patient factors):

  • First-line agents per local antibiogram
  • Duration: typically 3-7 days for uncomplicated cystitis
  • Obtain urine culture before treatment if recurrent UTI (≥2 episodes in 6 months) 2

Patient Education:

VVC:

  • Complete full course even if symptoms improve
  • Avoid sexual intercourse until treatment completed and asymptomatic
  • Partner treatment NOT routinely indicated (VVC not sexually transmitted) 4
  • Return if symptoms persist after treatment or recur within 2 months 4
  • Avoid unnecessary antimycotic therapy 5

UTI:

  • Increase fluid intake
  • Complete antibiotic course as prescribed
  • Return if symptoms worsen, fever develops, or no improvement in 48-72 hours

Follow-Up:

  • No routine follow-up needed if asymptomatic after treatment 1
  • Return visit if:
    • Symptoms persist or recur
    • Three or more VVC episodes per year (requires evaluation for predisposing conditions and consideration of maintenance therapy) 4
    • Recurrent UTI (≥2 episodes in 6 months requires further evaluation) 2

Red Flags Requiring Urgent Evaluation:

  • Fever, chills, flank pain (suggests pyelonephritis)
  • Severe systemic symptoms
  • Pregnancy with symptoms
  • Immunocompromised state

ICD-10 Codes:

  • B37.3 Candidiasis of vulva and vagina
  • N39.0 Urinary tract infection, site not specified

CPT Codes:

  • 99213-99215 Office visit (based on complexity)
  • 87210 Wet mount preparation
  • 81001 Urinalysis, automated with microscopy

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.